Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from SSY Group ( (HK:2005) ) is now available.
SSY Group shareholders approved all resolutions at the 2026 annual general meeting, with 2.90 billion shares eligible to vote after excluding treasury stock and shares held under the restricted share award scheme. All directors attended in person or electronically, and the meeting confirmed strong shareholder participation across the register.
Investors adopted the 2025 audited financial statements, re-elected three directors, authorized the board to set director pay, and reappointed KPMG as auditor. Shareholders also approved a final dividend and granted broad mandates for share issuance, repurchase, and mandate extension, reinforcing the board’s financial flexibility and signaling continued support for the company’s capital management strategy.
The most recent analyst rating on (HK:2005) stock is a Buy with a HK$5.00 price target. To see the full list of analyst forecasts on SSY Group stock, see the HK:2005 Stock Forecast page.
More about SSY Group
SSY Group Limited is a Cayman Islands-incorporated company listed in Hong Kong, operating in the pharmaceutical sector with a focus likely on injectable and related products, given its historical positioning in the healthcare industry. The company serves domestic and international markets, leveraging its manufacturing capabilities and R&D to supply hospitals and medical institutions with a range of specialty pharmaceutical products.
Average Trading Volume: 9,751,221
Technical Sentiment Signal: Sell
Current Market Cap: HK$6.94B
See more data about 2005 stock on TipRanks’ Stock Analysis page.